ArabFinance: October Pharma approved on December 9th the budget of 2021, targeting net profit after tax of EGP 91.4 million, according to the company’s statement filed to the Egyptian Exchange.
The company targeted sales of EGP 655 million in 2021, as well as ratified the investment budget of EGP 83.8 million.
October Pharma reported a 228% Year on Year jump in its net profit for the first nine months of 2020.
October Pharma is an Egypt-based company engaged in the production of human pharmaceutical preparations.
The company’s major shareholders include the Arab Company for Drug Industries and Medical Appliances as well as the Saudi-Egyptian Industrial Investment Company.
